Skip to content

LifeMD, Inc. LFMD Amortization Of Debt Discount Premium

Amortization Of Debt Discount Premium at other companies

PTH
Pelthos Therapeutics Inc.PTHS

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfDebtDiscountPremium.

The official record: LifeMD, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s amortization of debt discount premium.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s amortization of debt discount premium?
LifeMD, Inc. (LFMD) reported amortization of debt discount premium of $0 in Q4 2025.
How has LifeMD, Inc.'s amortization of debt discount premium changed year-over-year?
LifeMD, Inc.'s amortization of debt discount premium decreased by 100.0% year-over-year, from $100.44K to $0.
What is the long-term trend for LifeMD, Inc.'s amortization of debt discount premium?
Over 3 years (2021 to 2025), LifeMD, Inc.'s amortization of debt discount premium has grown at a -52.4% compound annual growth rate (CAGR), from $2.17M to $234.37K.